Leadership

Eric Dobmeier photo

Eric Dobmeier
President and Chief Executive Officer

Tom Frohlich photo

Tom Frohlich
Chief Business Officer

Andrew King photo

Andrew King, DVM, PhD
Head of Renal Discovery and Translational Medicine

Renata Oballa photo

Renata Oballa, PhD
VP, Chemistry

David Percival photo

David Percival, PhD
VP, Biology

Sarah Noonberg photo

Sarah Noonberg, MD, PhD
Consulting Chief Medical Officer


Team

Dave Powell photo

David Powell, PhD
Executive Director, Chemistry

Ram Ramachandran photo

C. Ramachandran, PhD
Executive Director, Biology

Allison Gaw photo

Allison Gaw
Executive Director, Business and Corporate Development

Ramtin Jamshidi photo

Ramtin Jamshidi
Controller

Maggie Alonso photo

Magdalena Alonso, PhD
Director, Pharmacology

Jen Cox photo

Jennifer Cox, PhD
Director, Biology

Bob Gomez photo

Bob Gomez
Asst Director, Chemistry

Toa Sheng photo

Tao Sheng, MSc
Sr. Scientist II

Jayakumar Surendradoss photo

Jayakumar Surendradoss, PhD
Sr. Scientist II

Jim Ding photo

Jim Ding, PhD
Sr. Scientist II

Joyce Wu photo

Joyce Wu, MSc
Scientist I

Oliver Chong photo

Oliver Chong
Research Associate I

Jeff Lester photo

Jeff Lester, MSc
Associate Pharmacologist

Tia Sanat photo

Tia Sanat
Administrative Assistant II

Board of Directors

Jerel Davis
Managing Director, Versant

Paul Eisenberg
Venture Partner, CMO

Srini Akkaraju
Managing GP, Samsara Biocapital

Jeremy Caldwell
CEO, Inception Therapeutics

Eric Dobmeier
CEO, Chinook Therapeutics

Scientific Advisory Board

Benjamin Humphreys, MD, PhD
Chief of the Division of Nephrology at Washington University‚Äč

Michael Caplan, MD, PhD
Professor of Cell Biology, C.N.H Long Professor of Cellular and Molecular Physiology and Chair, Cellular and Molecular Physiology at Yale University‚Äč

Benjamin Freedman, PhD
Assistant Professor, Division of Nephrology at University of Washington

Peter Harris, MD, PhD
Associate Director of the Translational Polycystic Kidney Disease Institute at Mayo Clinic

Ross Holmes, PhD
Professor, Department of Urology at University of Alabama at Birmingham (UAB)

John Knight, PhD
Assistant Professor, Department of Urology at University of Alabama at Birmingham (UAB)

W. Todd Lowther, PhD
Professor, Biochemistry at Wake Forest School of Medicine

Michal Mrug, MD
Professor of Medicine at University of Alabama at Birmingham (UAB), and Director of the Therapeutics Screening and Drug Development Resource (Core D) at the Hepatorenal Fibrocystic Disease Core Center; also Chair of the PKD Foundation Scientific Advisory Committee

Vicente Torres, MD, PhD
Director of the Translational Polycystic Kidney Disease Institute at Mayo Clinic

Darren Wallace, PhD
Associate Director of the Kansas PKD Research and Translation Core Center, and Director of the PKD Biomarkers and Biomaterials Core at the University of Kansas Medical Center

Thomas Weimbs, PhD
Professor, Department of Molecular, Cellular, and Developmental Biology at the University of California Santa Barbara